Danpure C J
Biochem J. 1981 Dec 15;200(3):555-63. doi: 10.1042/bj2000555.
The present study concerns the effect of the lysosomotropic drug chloroquine on the uptake and metabolism of [35S]cystine in vitro by normal human fibroblasts and those from patients suffering from the lysosomal storage disease cystinosis. When the cells were cultured with [35S]cystine for periods in excess of 4 h, it was found that chloroquine considerably increased (up to 30-fold) the labelling of the intracellular cystine pool in cystinotic cells, with no increase or a much smaller increase in normal cells. For this effect chloroquine had an optimum concentration of 20 microM, with a small effect still being noticeable at 1 microM. A quinoline analogue, 4-(dimethylaminoethylamino)-7-iodoquinoline, had a similar effect to chloroquine. However, NH4Cl at concentrations of between 100 microM and 50 mM showed either no effect (at the lower concentrations) or a depression of intracellular cystine labelling (at the higher concentrations). The differences between the effects of the quinolines on cystinotic acid normal cells were not due to differences in total cell uptake of drug.
本研究关注溶酶体亲和性药物氯喹对正常人成纤维细胞以及患有溶酶体贮积病胱氨酸病患者的成纤维细胞在体外摄取和代谢[35S]胱氨酸的影响。当细胞与[35S]胱氨酸一起培养超过4小时时,发现氯喹可显著增加(高达30倍)胱氨酸病细胞内胱氨酸池的标记,而正常细胞中无增加或增加幅度小得多。对于此效应,氯喹的最佳浓度为20微摩尔,在1微摩尔时仍有小的效应。喹啉类似物4-(二甲基氨基乙氨基)-7-碘喹啉具有与氯喹类似的效应。然而,浓度在100微摩尔至50毫摩尔之间的氯化铵要么无效应(较低浓度时),要么降低细胞内胱氨酸标记(较高浓度时)。喹啉对胱氨酸病细胞和正常细胞作用的差异并非由于药物的总细胞摄取不同。